Walgreens | GenomeWeb

Walgreens

So Many Voided

In its lawsuit papers, Walgreens says Theranos voided more than 11 percent of test reports sent to Walgreens customers, according to the Wall Street Journal.

Pharmacy company Walgreens sues its former partner for $140 million in damages, according to the Wall Street Journal.

Walgreens has terminated its partnership with blood-testing firm Theranos, the Wall Street Journal reports.

Glossed Over It

The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.

Pharmacy chain Walgreens seeks to terminate its relationship with Theranos, and may be exploring one with 23andMe.

Thirty Days

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Using gene expression data combined with bioinformatic analyses, scientists at the University of Georgia and China's Jilin University are developing a urine-based protein biomarker test for gastric cancer that they hope to offer as a direct-to-consumer diagnostic.

FDA believes Pathway Genomics is offering a device that has not been cleared for marketing by the agency, and that the firm has "moved outside of the currently sanctioned boundaries for lab-developed tests by marketing a product in a retail store that asks consumers to collect the sample."

Walgreens will sell the DTC genetic testing firm's saliva collection kits, which consumers can use in the process of ordering genetic tests on Pathway Genomics' website.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.